Small Business

Aarti drugs up on capex plans

Aarti Drugs closed at Rs 108, higher by Rs 2 or 2.8%, on the BSE. - Ashok Leyland gains on Dec sales jump - Sensex slips 75pts amid lacklustre trade - Sensex ends down 75 pts - Maha Govt blocks moneycontrol.com, bseindia.com for its staff - Another lacklustre day - Kalpataru Power advances on winning orders The stock opened at Rs 87, which also happened to be the day"s low, and a high of Rs 111 during the day. A total of 1.76 lakh shares were traded on the BSE as against the two-week average of 0.55 lakh shares. -----------------------------------------------------------------------------------(Updated at 0956am) Aarti Drugs has gained in morning trades on plans of expansion. The stock jumped 4% to touch a high of Rs 109. The stock is currently trading at Rs 107 - up 2%. Around 7,908 shares have been trded on the BSE so far. The company is considering a proposal for capital expenditure aggregating up to Rs 40 crore by way of expansion and acquisition. The capex will be funded by external commercial borrowing.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):